Purchase Order 68HE0B25P0207

Award Date 1/23/25
Potential Completion Date 9/5/25
Potential Value $41K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Greenland, NH 03840, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Environmental Protection Agency's Office of Research and Development awarded a firm-fixed-price purchase order contract to Lexogen Inc., a foreign-owned, for-profit transcriptomics and next-generation sequencing company, for the provision of CorAll Prep Kits and PCR Add-On Kits. The potential value of the contract is $67,635.71, and the period of performance ends on December 30, 2022. Lexogen Inc. has previously supplied various molecular library preparation kits and RNA sequencing kits...
The Environmental Protection Agency Office of Research and Development awarded a firm fixed price purchase order to Lexogen Inc., a foreign-owned for-profit transcriptomics and next generation sequencing company, to provide molecular library preparation kits. This $62,914.40 contract has no set-aside designation and will support the EPA's efforts to analyze up to 500 water and soil samples per month using gas chromatography-mass spectrometry for contaminant detection and remediation research....
This firm-fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to Lexogen Inc., a foreign-owned, for-profit transcriptomics and next generation sequencing company. The contract is for an MRNA-SEQ LIBRARY PREP KIT, with a potential value of $3,860.00 and a completion date of July 20, 2018. The contract does not have a set-aside designation. Lexogen Inc. has previously...
The U.S. Environmental Protection Agency (EPA) Office of Research and Development awarded a Firm Fixed Price Purchase Order contract to Qiagen, LLC, a division of the international provider Qiagen N.V., for $18,026.42 to provide Analytical RNA Sequencing services. The contract does not have a set-aside designation. Qiagen is an experienced federal contractor, having provided a range of products and services including DNA/RNA extraction kits, next-generation sequencing, digital PCR systems,...
The Environmental Protection Agency (EPA) Office of Research and Development awarded a firm fixed price purchase order to Illumina, Inc. for the supply of NovaSeq 6000 and NextSeq reagent kits. The contract has a potential value of $52,482.40 and a completion date of March 15, 2024. The contract does not have a set-aside designation. Illumina, a for-profit manufacturer of genomic analysis instruments and reagents, has previously provided similar sequencing products and services to support...
The Environmental Protection Agency (EPA) Office of Research and Development awarded a $31,200 firm-fixed-price purchase order to Diagenode, LLC for Infinium Methylation EPIC Arrays. This genomic analysis tool supports the agency's research mission related to areas such as human health and environmental studies. Diagenode, LLC is a global leader in epigenetics research that has received numerous prime and subcontracts from federal agencies. The contract has a period of performance through...
The Environmental Protection Agency (EPA) Office of Research and Development awarded a firm-fixed-price purchase order to Life Technologies Corporation, now part of Thermo Fisher Scientific Inc., for the delivery of two Luminex xMAP INTELLIFLEX DRSE RUO Instruments. The $249,481.80 contract, awarded on February 15, 2024, is for instruments to be used at the agency's research facilities in North Carolina, Ohio, and California. The solicitation did not use any set-asides. Life Technologies...
This is a firm fixed price purchase order awarded by the Environmental Protection Agency's (EPA) Office of Research and Development to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The contract, valued at $13,888.29, is for the provision of Illumina sequencing reagents and kits to support the agency's FY24 REICHMAN research programs focused on PFAS (per- and polyfluoroalkyl substances) and other scientific priorities. The award has a period of...
This award is for a firm fixed price Blanket Purchase Agreement (BPA) call task order from the U.S. Environmental Protection Agency (EPA) Office of Research and Development to Biospyder Technologies, Inc. (doing business as Biospyder), a for-profit small business manufacturer of genomic analysis services and products. The task order, titled "TRANSCRIPTOMICS PHASE 2," has a potential value of $158,124.96 and a completion date of April 19, 2020. This award is not set aside and is...
The Environmental Protection Agency (EPA) Office of Research and Development awarded a Firm Fixed Price contract to Biospyder Technologies, Inc. (doing business as Biospyder), a for-profit small business manufacturer, to provide Transcriptomics Phase 2 services. The $175,694.40 contract supports Biospyder's Tempo-Seq targeted gene expression analysis to assess impacts on transcriptomic profiles, including sample preparation, sequencing, bioinformatics processing, and data analysis. This work...

The federal government, specifically the Environmental Protection Agency's Office of Research and Development, has awarded a $41,419.60 firm-fixed-price purchase order contract to Lexogen Inc., a foreign-owned, for-profit company specializing in transcriptomics and next-generation sequencing technology. The contract is for the delivery of Lexogen Molecular Kits, which include products such as CorAll Prep Kits, QuantSeq 3' mRNA-Seq Library Prep Kits, Sense mRNA-Seq Library Prep Kits, and PCR Add-On Kits. These specialized molecular kits support the EPA's research efforts, including contaminant detection, remediation research, and gene expression analysis. The contract has an ultimate completion date of September 5, 2025. This procurement is a sole source award and does not have a set-aside designation.

Generated 1/30/25, 9:09 AM